How do PARP inhibitors fit within the ovarian treatment landscape?
In session 1, Professor Isabelle Ray-Coquard discusses the PARP inhibitors indicated for use in people with ovarian cancer, and how PARP inhibitor therapy interplays with traditional cancer treatments such as chemotherapy.